Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M. Huffman, Samuel J. Klempner, Griffin Budde et al.|JCO Precision Oncology|2022Cited by 72
Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide <i>in vitro</i> and in a mouse modelMeenakshi Malhotra, Tarik F. Massoud|Oncotarget|2018Cited by 70